Piper Sandler analyst Rob Owens raised the firm’s price target on Varonis (VRNS) to $55 from $48 and keeps a Neutral rating on the shares. The firm notes Q3 results surpassed expectations across both ARR and free cash flow, though guidance lacked the follow-through to this momentum that many had hoped for, with Q4 NNARR implying a steep deceleration in growth.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks